Sunday, June 13, 2021
Home Tags DCGI

Tag: DCGI

Alkem launches Drug for Epilepsy treatment in India

Alkem Laboratories Ltd, one of the India's leading pharmaceutical formulation development, manufacturing, and marketing companies, announces the launch of Perampil (perampanel) tablets...

Black Fungus: Mankind Pharma launches drug for treatment

Mankind Pharma on Thursday said it has launched Posaconazole Gastro resistant tablets, used to treat black fungus, in the country. The company has launched...

Govt issues guidelines for Rational use of medicines, tests for C-19

Govt issues guidelines for Rational use of medicines, tests for C-19 NEW DELHI: The Union Health Ministry on Monday dropped...

60 million doses of Sputnik V vaccine to be supplied to...

The Haryana government has received an expression of interest from an international pharma company headquartered in Malta to provide up to 60...

Serum gets nod from DCGI to produce Sputnik V vaccine in...

The DCGI has granted permission to the Serum Institute of India (SII) to manufacture the Sputnik C-19 vaccine in India for examination,...

Zydus Cadila gets nod for Clinical Trials of Antibodies cocktail

New Delhi: The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of C-19 has been given...

Serum Institute seeks DCGI’s nod to manufacture Sputnik V vaccine

New Delhi: The Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture the Sputnik V C-19 vaccine for...

Sun Pharma, Ferring Pharma sign agreement to launch CARITEC in India

Sun Pharmaceutical Industries announced that one of its wholly owned subsidiaries has entered into a license agreement with Ferring Pharmaceuticals, a subsidiary...

Green signal: Moderna vaccines may soon be available in India

The Drugs Controller General of India (DCGI) has given a green signal to foreign vaccines to be approved in India without specific clinical trials in the country before...

DCGI issues safety alerts on Medical Devices

The Drugs Controller General of India (DCGI) has issued safety alerts on medical devices related to orthopaedic, neurosurgery and eye related disorders...

Bal Pharma launches Favipiravir tablets in India

Bal Pharma announced the launch of Favipiravir formulation in the Indian market, under the brand name BALflu. Favipiravir is...

Bharat Parenterals gets DCGI nod for Favipiravir oral suspension

Drug firm Bharat Parenterals on Saturday said it has received approval from the Drugs Controller General of India (DCGI) for favipiravir oral suspension, to be used for...

Black Fungus: MSN Labs launches Posaconazole to treat black fungus

MSN Laboratories has launched posaconazole in India under the brand name PosaOne as 100 mg delayed release tablets & 300 mg injections...

Optimus Pharma gets DCGI nod for Phase III trials of Molnupiravir

Optimus Pharma received DCGI nod for conducting Phase III clinical trials for orally administered Molnupiravir capsules on patients with mild to moderate...

Baricitinib: BDR Pharma signs licensing agreement with Lilly

BDR Pharma has entered into a royalty-free, limited and non-exclusive voluntary licensing agreement with Eli Lilly and Company, for the manufacturing and...

Bring Nutraceuticals for prevention of diseases under DCGI’s regulation: Experts to...

Regulatory oversight and lack of clarity on upper tolerable limit (UTL) and recommended dietary allowance (RDA) standards have prompted manufacturers across the...

DRDO launches anti-C-19 drug 2-DG

The first batch of DRDO developed anti-C-19 drug 2-DG (2-deoxy-D-glucose) has been launched to treat patients suffering from the deadly C-19. The...

Zydus Cadila’s Virafin priced at Rs 11,995 per dose

As per reports, Zydus Cadila has fixed the price of Virafin, a medicine that has received EUA for C-19 treatment, at Rs...

Anti C-19 drug developed by DRDO gets DCGI nod

An anti-C-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a...

IPC starts verifying testing protocols for DCGI approved drugs

The Indian Pharmacopoeia Commission (IPC) has started verifying the testing protocols for Drugs Controller General of India (DCGI) approved drugs recently introduced...

Bharat Biotech seeks DCGI’s nod to extend shelf life of Covaxin

Bharat Biotech has written to the India’s drug regulator (DCGI) seeking extension of the shelf-life of its indigenously developed C-19 vaccine Covaxin...

Oral dose of Remdesivir: Jubilant completes studies

Jubilant Pharmova on Monday said its arm Jubilant Pharma has successfully completed studies using a novel oral formulation of Remdesivir used for treatment of C-19 against the available injectable formulation...

Import of drugs with residual shelf life: deadline extended till October...

The Drugs Controller General of India (DCGI) has extended the deadline till October 31, 2021 for allowing import of drugs with residual...

Latest Circulars, Notices & Guidelines: CDSCO, DCGI

Circulars – CDSCO, DCGI Govt of India, DCGI, Health Ministry, ICMR issues notices / circulars time to time for...

Latest posts

C-19: बच्चों का संक्रमण से कैसे करें बचाव: Lets Know

C-19 की पहली लहर ने बुजुर्गों को ज़्यादा प्रभावित किया था और इसकी दूसरी लहर ने युवाओं को. इससे अब यह अन्दाजा...

Authors

30 POSTS0 COMMENTS
23 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS